Your browser doesn't support javascript.
loading
The recombinant defensin/HSA fusion protein that inhibits NF-κb associated with intensive macropinocytosis shows potent efficacy against pancreatic cancer.
Du, Yi-Bo; Wang, Xiao-Fei; Liu, Xiu-Jun; Li, Yi; Miao, Qing-Fang; Jiang, Min; Sheng, Wei-Jin; Zhen, Yong-Su.
Afiliación
  • Du YB; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Wang XF; Lepu Biopharma Co., Ltd., Beijing 101204, China.
  • Liu XJ; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Li Y; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Miao QF; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Jiang M; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Sheng WJ; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: swj_zjnb@imb.cams.cn.
  • Zhen YS; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: zhenys@imb.pumc.edu.cn.
Biochem Pharmacol ; 201: 115057, 2022 07.
Article en En | MEDLINE | ID: mdl-35489393

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / FN-kappa B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / FN-kappa B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article